drugset / Trial / NCT06059326
Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DM
RandomizedSequentialDouble-blindTreatment
Summary
To evaluate the safety, tolerability and pharmacokinetic (PK)/pharmacodynamic (PD) characteristics of HSK7653 tablets in Type 2 Diabetes Mellitus Patients.
Timeline
- Start
- 2019-01-22
- Primary completion
- 2019-11-05
- Completion
- 2019-11-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK7653 | Unknown | 10 mg | — |
| Subject | HSK7653 | Unknown | 25 mg | — |
| Subject | HSK7653 | Unknown | 50 mg | — |